TPG Growth would invest $30m in Solara Active Pharma, a leading global manufacturer of active pharmaceutical ingredients with a network of customers including several top global generic companies in the US and Europe. "We are excited about partnering with Arun Kumar and the Solara management team to build the company as a leading global API business and expand on our global healthcare efforts," said Matthew Hobart, Senior Partner and Head of Healthcare Investing, TPG Growth. "This is a unique opportunity, and Solara is poised for success given its regulated market capability, strong customer base and leadership in key molecules."